Whiteoak Capital Pharma And Healthcare Fund Overview
Category Pharma Fund
BMSMONEY Rank N/A
BMSMONEY Rating N/A
Gro. Opt. As On: 31-12-2024
NAV ₹13.72(R) +0.29% ₹13.94(D) +0.29%
Returns 1Y 3Y 5Y 7Y 10Y
LumpSum (R) -% -% -% -% -%
LumpSum (D) -% -% -% -% -%
SIP (R) -% -% -% -% -%
SIP (D) -% -% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
Top Pharma Fund
Fund Name Rank Rating
Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
Sbi Healthcare Opportunities Fund -
Dsp Healthcare Fund -
Tata India Pharma & Healthcare Fund -
Uti Healthcare Fund -

NAV Date: 31-12-2024

Scheme Name NAV Rupee Change Percent Change
WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth 13.72
0.0400
0.2900%
WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth 13.94
0.0400
0.2900%

Review Date: 31-12-2024

A review of the different performance parameters of the fund is as follows:
  1. Returns: It indicates the appreciation in the investment's value within the investment period, represented as a percentage or a specific amount of money. We conducted an analysis of the three return parameters of this fund to assess their performance. To assess performance, we have segmented the return parameters into three groups: the top 25%, parameters below the top 25% but still above average, and parameters below average. The results are provided below.
    1. Top 25%: Two return parameters of the Whiteoak Capital Pharma And Healthcare Fund are in the top 25% in the category, as shown below:
      • 3M Return %
      • 6M Return %
    2. Above Average Below the Top 25%: The Whiteoak Capital Pharma And Healthcare Fund has one return parameter in the category, which is above average but below the top 25%, as listed below:
      • 1M Return %
    3. Below Average: Whiteoak Capital Pharma And Healthcare Fund has no return parameters that are below average in the category.
  2. Risk: It is defined as the prospect of not attaining expected yields or enduring financial setbacks due to numerous causes. For Whiteoak Capital Pharma And Healthcare Fund, we have analyzed zero risk parameters and divided them into three groups the lowest 25%, below average but above the lowest 25%, and above average, which are described below.
    1. Lowest 25%: Whiteoak Capital Pharma And Healthcare Fund does not have any risk parameters in the lowest 25% of the category. It means high risk compared to other funds in the category.
    2. Below Average but Above the Lowest 25%: Whiteoak Capital Pharma And Healthcare Fund does not have any risk parameters in the below average but above the lowest 25% of the category.
    3. Above Average: Whiteoak Capital Pharma And Healthcare Fund does not have any risk parameters above average; which is a good sign.
  3. Risk Adjusted Performance Parameters: Risk-adjusted performance parameters in mutual funds are parameters that assess the return on investments based on the risks involved. These parameters provide a platform for investors to compare various investments, by considering both profits and the risks involved. For Whiteoak Capital Pharma And Healthcare Fund, we have evaluated zero risk-adjusted performance parameters.
    1. Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the top 25% of the category.
    2. Above Average Below Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.
    3. Below Average Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.


Not able to see in mobile!!! save the chart by clicking on camera icon.

KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 2.89
1.71
-3.55 | 3.47 5 | 13 Good
3M Return % 5.61
1.68
-7.88 | 5.61 1 | 13 Very Good
6M Return % 28.93
21.61
5.96 | 28.93 1 | 13 Very Good
Return data last Updated On : Dec. 31, 2024.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Nov. 29, 2024
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 3.02 1.81 -3.42 | 3.59 5 | 13
3M Return % 6.06 2.01 -7.50 | 6.06 1 | 13
6M Return % 30.03 22.40 6.85 | 30.03 1 | 13
Return data last Updated On : Dec. 31, 2024.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Nov. 29, 2024
KPIs: Key Performance Indicators

Investment Period Regular Direct
Return % Current Value of ₹ 10000 Return % Current Value of ₹ 10000
1D 0.29 ₹ 10,029.00 0.29 ₹ 10,029.00
1W 2.43 ₹ 10,243.00 2.47 ₹ 10,247.00
1M 2.89 ₹ 10,289.00 3.02 ₹ 10,302.00
3M 5.61 ₹ 10,561.00 6.06 ₹ 10,606.00
6M 28.93 ₹ 12,893.00 30.03 ₹ 13,003.00
1Y ₹ ₹
3Y ₹ ₹
5Y ₹ ₹
7Y ₹ ₹
10Y ₹ ₹
15Y ₹ ₹

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.

Investment Period Invested Amount Regular Direct
XIRR % Current Value of Invested Amount XIRR % Current Value of Invested Amount
1Y ₹ 12000 ₹ ₹
3Y ₹ 36000 ₹ ₹
5Y ₹ 60000 ₹ ₹
7Y ₹ 84000 ₹ ₹
10Y ₹ 120000 ₹ ₹
15Y ₹ 180000 ₹ ₹


Date Whiteoak Capital Pharma And Healthcare Fund NAV Regular Growth Whiteoak Capital Pharma And Healthcare Fund NAV Direct Growth
31-12-2024 13.722 13.942
30-12-2024 13.682 13.901
27-12-2024 13.526 13.741
26-12-2024 13.434 13.646
24-12-2024 13.396 13.606
23-12-2024 13.371 13.58
20-12-2024 13.358 13.566
19-12-2024 13.476 13.685
18-12-2024 13.392 13.598
17-12-2024 13.282 13.486
16-12-2024 13.302 13.506
13-12-2024 13.297 13.499
12-12-2024 13.351 13.554
11-12-2024 13.437 13.64
10-12-2024 13.409 13.61
09-12-2024 13.403 13.604
06-12-2024 13.433 13.632
05-12-2024 13.443 13.642
04-12-2024 13.432 13.63
03-12-2024 13.397 13.594
02-12-2024 13.337 13.533

Fund Launch Date: 06/Feb/2024
Fund Category: Pharma Fund
Investment Objective: To provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. There is no assurance that the investment objective of the Scheme will be achieved.
Fund Description: An open ended equity scheme investing in Pharma and Healthcare sector
Fund Benchmark: BSE Healthcare Total Return Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.